We analyzed comprehensive genomic data across numerous solid tumor types from TCGA to examine Trop-2 mRNA expression and determine the relative expression of Trop-2 in NSCLC in a pan-cancer comparison of 32 solid tumor indications. This evidence concerns the gene TACSTD2 and non-small cell lung carcinoma.